Skip to main content
Fig. 2 | Alzheimer's Research & Therapy

Fig. 2

From: CSF biomarker analysis of ABCA7 mutation carriers suggests altered APP processing and reduced inflammatory response

Fig. 2

Aβ1–42 and Aβ ratio levels along APOE ε4 and ABCA7 carrier status in the Aβ-positive cohort. Median Aβ1–42 (a, b) and Aβ ratio (c, d) levels according to APOE ε4 status and further stratified for ABCA7 mutation carrier status (a, c) or VNTR expansion carrier status (b, d) in the Aβ-positive cohort. Significance was assessed with a Mann–Whitney U test on untransformed data. *P < 0.05

Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193